Corticosteroids and growth (Q39654862)

13 September 2017

1 reference

title

Corticosteroids and growth (English)

1 reference

13 September 2017

Hyams JS

1

1 reference

PubMed ID

3294360

13 September 2017

Carey DE

series ordinal

2

1 reference

PubMed ID

3294360

13 September 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

The Journal of Pediatrics

13 September 2017

1 reference

13 September 2017

113

1 reference

13 September 2017

2

1 reference

13 September 2017

249-254

1 reference

Growth and Skeletal Maturation in Asthmatic Children: Effect of Corticosteroid Treatment

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of exogenous corticosteroid therapy on growth in children with HBsAg-negative chronic aggressive hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of height of corticosteroid therapy in asthmatic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Normal growth of nephrotic children during long-term alternate-day prednisone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Growth, pulmonary, and endocrine function in chronic asthma patients on daily and alternate-day adrenocorticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

ALTERNATE-DAY STEROID THERAPY FOR NEPHROTIC CHILDREN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Prolonged intermittent steroid therapy for nephrosis in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of corticotorphin on skeletal maturation and linear growth in six patients with severe asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Osteoporosis of rheumatoid arthritis: Influence of age, sex and corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of cortisone treatment on the active transport of calcium by the small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Plasma growth hormone concentration in corticosteroid-treated children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Studies of the secretion and metabolic effects of human growth hormone in children with glucocorticoid-induced growth retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Basal and Stimulated Serum Growth Hormone Concentrations in Inflammatory Bowel Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Pituitary growth hormone suppression withlow-dosage, long-acting corticoid administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Metabolic effects of human growth hormone in corticosteroid-treated children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of administered human growth hormone on growth retardation in inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Somatomedins (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Somatomedin A levels in patients with Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Glucocorticoid therapy in children. Effect on somatomedin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Steroid Hormone Effects on Somatomedin. I. Somatomedin Action in Vitro1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Somatomedin inhibitor in uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

The biosynthesis of collagen and its disorders (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Effect of cortisol acetate on collagen biosynthesis and on the activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in chick-embryo tendon cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Collagen fibril formation during embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Biosynthesis of Procollagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Catch-up growth following illness or starvation. An example of developmental canalization in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Catch-up growth in cortisone-treated rats: effects of calcium and vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Height attainment in children with steroid-responsive nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980260-9

10.1016/S0022-3476(88)80260-9

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

3294360